Geneos Wealth Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.79K | Sell |
213
-213
| -50% | -$3.79K | ﹤0.01% | 2649 |
|
2025
Q1 | $7.59K | Buy |
+426
| New | +$7.59K | ﹤0.01% | 2651 |
|
2023
Q4 | – | Sell |
-40
| Closed | -$646 | – | 2146 |
|
2023
Q3 | $646 | Hold |
40
| – | – | ﹤0.01% | 2075 |
|
2023
Q2 | $1.66K | Buy |
+40
| New | +$1.66K | ﹤0.01% | 1956 |
|
2022
Q4 | – | Sell |
-90
| Closed | -$6K | – | 2071 |
|
2022
Q3 | $6K | Sell |
90
-45
| -33% | -$3K | ﹤0.01% | 1653 |
|
2022
Q2 | $9K | Hold |
135
| – | – | ﹤0.01% | 2001 |
|
2022
Q1 | $11K | Sell |
135
-10
| -7% | -$815 | ﹤0.01% | 2056 |
|
2021
Q4 | $10K | Buy |
+145
| New | +$10K | ﹤0.01% | 2184 |
|
2019
Q1 | – | Sell |
-200
| Closed | -$6K | – | 2450 |
|
2018
Q4 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1943 |
|
2016
Q2 | – | Sell |
-100
| Closed | -$1K | – | 1830 |
|
2016
Q1 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 1738 |
|